- Home
- CDNA vs RC Comparison
CDNA vs RC Comparison
Compare CDNA & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- RC
- Stock Information
- Founded
- CDNA 1998
- RC 2007
- Country
- CDNA United States
- RC United States
- Employees
- CDNA N/A
- RC N/A
- Industry
- CDNA Medical Specialities
- RC Real Estate Investment Trusts
- Sector
- CDNA Health Care
- RC Real Estate
- Exchange
- CDNA Nasdaq
- RC Nasdaq
- Market Cap
- CDNA 1.1B
- RC 1.2B
- IPO Year
- CDNA 2014
- RC N/A
- Fundamental
- Price
- CDNA $18.92
- RC $5.07
- Analyst Decision
- CDNA Buy
- RC Hold
- Analyst Count
- CDNA 8
- RC 8
- Target Price
- CDNA $29.43
- RC $8.00
- AVG Volume (30 Days)
- CDNA 912.4K
- RC 3.7M
- Earning Date
- CDNA 05-08-2025
- RC 03-03-2025
- Dividend Yield
- CDNA N/A
- RC 18.23%
- EPS Growth
- CDNA N/A
- RC N/A
- EPS
- CDNA 0.93
- RC N/A
- Revenue
- CDNA $333,785,000.00
- RC N/A
- Revenue This Year
- CDNA $13.32
- RC N/A
- Revenue Next Year
- CDNA $14.99
- RC $7.26
- P/E Ratio
- CDNA $20.44
- RC N/A
- Revenue Growth
- CDNA 19.07
- RC N/A
- 52 Week Low
- CDNA $7.42
- RC $4.74
- 52 Week High
- CDNA $34.84
- RC $9.54
- Technical
- Relative Strength Index (RSI)
- CDNA 36.93
- RC 29.62
- Support Level
- CDNA $17.73
- RC $4.97
- Resistance Level
- CDNA $22.61
- RC $5.48
- Average True Range (ATR)
- CDNA 1.31
- RC 0.30
- MACD
- CDNA -0.35
- RC -0.13
- Stochastic Oscillator
- CDNA 18.97
- RC 14.19
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.